FTC Orders 2 Generics Divested In $210M Pharma Deal
Two pharma companies must sell off their stakes in a pair of generic drugs and seek Federal Trade Commission approval for any future entry into those drug markets in order to...To view the full article, register now.
Already a subscriber? Click here to view full article